NCT07219459
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07219459
Title Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure (GDFATHERHCC01)
Acronym GDFATHERHCC01
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CatalYm GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
Peidmont Healthcare, Inc RECRUITING Atlanta Georgia 30309 United States Details
OSF St. Francis Medical Center RECRUITING Peoria Illinois 61637 United States Details
Hannover Medical School RECRUITING Hanover Lower Saxony 30625 Germany Details
University Medical Center of Johannes Gutenberg University Mainz RECRUITING Mainz Rhineland-Palatinate 55131 Germany Details
Universitätsklinikum Frankfurt Johann Wolfgang Goethe- Universität RECRUITING Frankfurt 60590 Germany Details
Polyclinic S. Orsola-Malpighi RECRUITING Bologna 40138 Italy Details
Asst Grande Ospedale Metropolitano Niguarda RECRUITING Milan 20162 Italy Details
Ospedale S.Maria delle Croci RECRUITING Ravenna 48121 Italy Details
University Hospital Miguel Servet RECRUITING Zaragoza Aragon 50009 Spain Details
Catalan Institute of Oncology, Hospital Duran i Reynals RECRUITING L'Hospitalet de Llobregat Barcelona 08908 Spain Details
Hospital Clinic of Barcelona RECRUITING Barcelona Catalonia 08036 Spain Details
University Clinic of Navarra - Pamplona RECRUITING Pamplona Chartered Community of Navarra 31008 Spain Details
University Hospital Ramon y Cajal RECRUITING Madrid Madrid 28034 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field